Is anyone else getting headaches from phenylpiracetam? It reads like a known thing in the literature and is oddly absent from the popular write-ups.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Headache is the classic first-week effect and choline usually sorts it.
Curious whether the popular dose has any basis or is just the convenient one.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
This board overrates bloodwork. A number moving is not the outcome you wanted.
This is the kind of post the forum exists for.